# Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

> **NCT02653560** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Potassium chloride powder
- **DRUG:** Potassium magnesium Citrate (KMgCit)
- **DRUG:** Potassium citrate powder
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02653560
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02653560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02653560, "Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02653560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*